Latest Juvenile Diabetes Research Foundation Stories
Program Focuses on Beta Cell Replication and Regeneration NEW YORK, March 22 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.
CAMBRIDGE, Mass., March 16 /PRNewswire/ -- Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3).
PHILADELPHIA, March 15 /PRNewswire/ -- When Lee Ducat, founder of the Juvenile Diabetes Research Foundation (JDRF), brought together a group of Philadelphia-area parents of children with juvenile diabetes on May 21, 1970, she could never have imagined that 40 years later that devoted group would have grown into an international organization that changed the world.
Scientists in Cambridge have made a significant step towards developing a so-called "artificial pancreas" system for managing type 1 diabetes in children.
-- Research Shows Closed-Loop Systems Control Diabetes, Reduce Dangerous Low Blood Sugar -- LONDON, Feb.
A hormone responsible for the body's stress response is also linked to the growth of insulin-producing cells in the pancreas, according to JDRF- funded researchers at the Salk Institute for Biological Studies in California.
GERMANTOWN, Md., Feb. 2 /PRNewswire/ -- Sensors for Medicine and Science, Inc., a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced the appointment of Dr.
R&D Program Targets Opportunities to Improve Glucose Control and Help People with Diabetes Lead Healthier Lives NEW YORK and FRANKLIN LAKES, N.J., Jan.
Patient Advocacy Partners Forge Collaboration to Fund Discovery of New Drugs that Target the Immune System NEW YORK and MILAN, Italy, Jan.
-- Partnership to develop automated system to better control diabetes represents first step on path to artificial pancreas -- NEW YORK, Jan.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.